- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-4-4-mer
- Ligands
- 4 x ZN: ZINC ION(Non-covalent)
- 8 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
ATP.2: 14 residues within 4Å:- Chain A: K.4166, K.4169, R.4170, I.4173, M.4884, K.4887, C.4888, F.4889, I.4890, F.4905, T.4909, H.4913, N.4914, L.4915
9 PLIP interactions:9 interactions with chain A- Hydrogen bonds: A:F.4889, A:T.4909, A:H.4913, A:L.4915
- Salt bridges: A:K.4166, A:K.4169, A:K.4169, A:K.4169, A:R.4170
ATP.3: 8 residues within 4Å:- Chain A: W.893, R.908, Q.927, E.928, Y.931, W.1007, R.1011, N.1029
7 PLIP interactions:7 interactions with chain A- Hydrogen bonds: A:R.908, A:R.908, A:E.928, A:W.1007, A:N.1029
- Salt bridges: A:R.1011, A:R.1011
ATP.5: 14 residues within 4Å:- Chain F: K.4166, K.4169, R.4170, I.4173, M.4884, K.4887, C.4888, F.4889, I.4890, F.4905, T.4909, H.4913, N.4914, L.4915
9 PLIP interactions:9 interactions with chain F- Hydrogen bonds: F:F.4889, F:T.4909, F:H.4913, F:L.4915
- Salt bridges: F:K.4166, F:K.4169, F:K.4169, F:K.4169, F:R.4170
ATP.6: 8 residues within 4Å:- Chain F: W.893, R.908, Q.927, E.928, Y.931, W.1007, R.1011, N.1029
7 PLIP interactions:7 interactions with chain F- Hydrogen bonds: F:R.908, F:R.908, F:E.928, F:W.1007, F:N.1029
- Salt bridges: F:R.1011, F:R.1011
ATP.8: 14 residues within 4Å:- Chain G: K.4166, K.4169, R.4170, I.4173, M.4884, K.4887, C.4888, F.4889, I.4890, F.4905, T.4909, H.4913, N.4914, L.4915
9 PLIP interactions:9 interactions with chain G- Hydrogen bonds: G:F.4889, G:T.4909, G:H.4913, G:L.4915
- Salt bridges: G:K.4166, G:K.4169, G:K.4169, G:K.4169, G:R.4170
ATP.9: 8 residues within 4Å:- Chain G: W.893, R.908, Q.927, E.928, Y.931, W.1007, R.1011, N.1029
7 PLIP interactions:7 interactions with chain G- Hydrogen bonds: G:R.908, G:R.908, G:E.928, G:W.1007, G:N.1029
- Salt bridges: G:R.1011, G:R.1011
ATP.11: 14 residues within 4Å:- Chain H: K.4166, K.4169, R.4170, I.4173, M.4884, K.4887, C.4888, F.4889, I.4890, F.4905, T.4909, H.4913, N.4914, L.4915
9 PLIP interactions:9 interactions with chain H- Hydrogen bonds: H:F.4889, H:T.4909, H:H.4913, H:L.4915
- Salt bridges: H:K.4166, H:K.4169, H:K.4169, H:K.4169, H:R.4170
ATP.12: 8 residues within 4Å:- Chain H: W.893, R.908, Q.927, E.928, Y.931, W.1007, R.1011, N.1029
7 PLIP interactions:7 interactions with chain H- Hydrogen bonds: H:R.908, H:R.908, H:E.928, H:W.1007, H:N.1029
- Salt bridges: H:R.1011, H:R.1011
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Miotto, M.C. et al., Structural basis for ryanodine receptor type 2 leak in heart failure and arrhythmogenic disorders. Nat Commun (2024)
- Release Date
- 2023-11-15
- Peptides
- Ryanodine receptor 2: AFGH
Peptidyl-prolyl cis-trans isomerase FKBP1B: BCDE - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AF
BG
CH
DB
EC
FD
GE
H - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-4-4-mer
- Ligands
- 4 x ZN: ZINC ION(Non-covalent)
- 8 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Miotto, M.C. et al., Structural basis for ryanodine receptor type 2 leak in heart failure and arrhythmogenic disorders. Nat Commun (2024)
- Release Date
- 2023-11-15
- Peptides
- Ryanodine receptor 2: AFGH
Peptidyl-prolyl cis-trans isomerase FKBP1B: BCDE - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AF
BG
CH
DB
EC
FD
GE
H - Membrane
-
We predict this structure to be a membrane protein.